An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

NCT02559232 · clinicaltrials.gov ↗

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke
Prevention and Control
Atrial Fibrillation

Interventions

DRUG: Direct Oral Anticoagulant (DOAC)

Sponsor

Bayer